These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38488201)

  • 1. Are international guideline recommendations for the management of placenta accreta spectrum applicable in low- and middle-income countries?
    Nieto-Calvache AJ; Jauniaux E; Fox KA; Maya J; Stefanovic V; Weizsäcker K; van Beekhuizen H; Adu-Bredu T; Collins S; Siaulys M; Hussein AM; Duvekot J; Aryananda R; Pajkrt E; Rijken MJ;
    Int J Gynaecol Obstet; 2024 Sep; 166(3):1047-1056. PubMed ID: 38488201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is telehealth useful in the management of placenta accreta spectrum in low-resource settings? Results of an exploratory survey.
    Nieto-Calvache AJ; Fox KA; Jauniaux E; Maya J; Stefanovic V; Weizsäcker K; van Beekhuizen H; Adu-Bredu T; Collins S; Siaulys M; Hussein AM; Duvekot J; Aryananda R; Nieto-Calvache AS; Pajkrt E; Rijken MJ;
    Int J Gynaecol Obstet; 2024 Sep; 166(3):1031-1039. PubMed ID: 38509726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colombian Consensus on the Treatment of Placenta Accreta Spectrum (PAS).
    Nieto-Calvache AJ; Sanín-Blair JE; Buitrago-Leal HM; Benavides-Serralde JA; Maya-Castro J; Rozo-Rangel AP; Messa-Bryon A; Colonia-Toro A; Gómez-Castro AR; Cardona-Ospina A; Caicedo-Cáceres CE; Dorado-Roncancio EF; Silva JL; Carvajal-Valencia JA; Velásquez-Penagos JA; Niño-González JE; Burgos-Luna JM; Rincón-García JC; Matera-Torres L; Villamizar-Galvis OA; Olaya-Garay SX; Medina-Palmezano VP; Castañeda J
    Rev Colomb Obstet Ginecol; 2022 Sep; 73(3):283-316. PubMed ID: 36331304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of placenta accreta spectrum in low- and middle-income countries.
    Nieto-Calvache AJ; Palacios-Jaraquemada JM; Hussein AM; Jauniaux E; Milani Coutinho C; Rijken M
    Best Pract Res Clin Obstet Gynaecol; 2024 Jun; 94():102475. PubMed ID: 38452606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International survey of practices used in the diagnosis and management of placenta accreta spectrum disorders.
    Cal M; Ayres-de-Campos D; Jauniaux E
    Int J Gynaecol Obstet; 2018 Mar; 140(3):307-311. PubMed ID: 29149470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placenta Accreta Spectrum: A Comprehensive Review of Guidelines.
    Giouleka S; Tsakiridis I; Chanioti ER; Ladas K; Liberis A; Mamopoulos A; Kalogiannidis I; Athanasiadis A; Dagklis T
    Obstet Gynecol Surv; 2024 Jun; 79(6):366-381. PubMed ID: 38896432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographic variation in management of patients with placenta accreta spectrum: An international survey of experts (GPASS).
    Brown AD; Hart JM; Modest AM; Hess PE; Abbas AM; Nieto-Calvache AJ; Bhide A; Lim B; Dunjin C; Palacios-Jaraquemada J; Sentilhes L; Soma-Pillay P; Aryananda RA; Hantoushzadeh S; Wang S; Shamshirsaz AA; Shainker SA
    Int J Gynaecol Obstet; 2022 Jul; 158(1):129-136. PubMed ID: 34610154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of adherence to French clinical practice guidelines in the management of pregnancy loss issued by the French College of Obstetricians and Gynecologists, one year after publication: A vignette-based study.
    Le Gouic S; Lavoué V; Mimouni M; Levêque J; Huchon C
    J Gynecol Obstet Hum Reprod; 2017 May; 46(5):393-398. PubMed ID: 28934082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful multidisciplinary team management of placenta accreta spectrum disorder: A referral center model in a middle-income country.
    Muadtongon K; Rattanaburi A; Ajimakul T; Suphasynth Y; Jiamset I; Nantamongkolkul K; Suntharasaj T; Suwanrath C; Pruksanusak N; Petpichetchian C; Suksai M; Chainarong N; Sawaddisan R; Pranpanus S
    Int J Gynaecol Obstet; 2024 May; 165(2):813-822. PubMed ID: 38189162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of abnormal invasive placenta in a low- and medium-resource setting.
    Escobar MF; Gallego JC; Nasner D; Gunawardana K
    Best Pract Res Clin Obstet Gynaecol; 2021 Apr; 72():117-128. PubMed ID: 32900599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difficulties in the Management of Placenta Accreta Spectrum in Hospitals with Limited Resources.
    Aguilera LR; Mojica-Palacios LM; Urquizu F; Gorena M; Tinajeros Guzmán F; Vergara Galliadi LM; Hidalgo A; Nieto-Calvache AJ
    Rev Bras Ginecol Obstet; 2022 May; 44(5):467-474. PubMed ID: 35472821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placenta Accreta Spectrum Disorders: A National Survey.
    Létourneau I; Hobson SR; Moretti F; Kingdom JC; Murji A; Windrim RC; Allen LM; Werlang A; Vachon-Marceau C; Singh SS
    J Obstet Gynaecol Can; 2023 Oct; 45(10):102167. PubMed ID: 37315785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of recent guidelines in the diagnosis and management of placenta accreta spectrum disorders.
    Jauniaux E; Kingdom JC; Silver RM
    Best Pract Res Clin Obstet Gynaecol; 2021 Apr; 72():102-116. PubMed ID: 32698993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placenta accreta spectrum disorders clinical practice guidelines: A systematic review.
    Capannolo G; D'Amico A; Alameddine S; Di Girolamo R; Khalil A; Calì G; Trish IT; Coutinho CM; Herrera M; Liberati M; Lucidi A; Palacios-Jaraquemada J; Buca D; D'Antonio F
    J Obstet Gynaecol Res; 2023 May; 49(5):1313-1321. PubMed ID: 36796351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placenta accreta spectrum: treatment consensus in a resource-limited setting.
    Nieto-Calvache AJ; Sanín-Blair JE; Buitrago M; Maya J; Benavides JA;
    AJOG Glob Rep; 2023 Aug; 3(3):100188. PubMed ID: 37456142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated with Adherence to Clinical Practice Guidelines for Patients with Type 2 Diabetes Mellitus: Results of a Spanish Delphi Consensus.
    Gimeno JA; Cánovas G; Durán A
    J Diabetes Res; 2021; 2021():9970859. PubMed ID: 34725642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter observational survey of management strategies in 442 pregnancies with suspected placenta accreta spectrum.
    van Beekhuizen HJ; Stefanovic V; Schwickert A; Henrich W; Fox KA; MHallem Gziri M; Sentilhes L; Gronbeck L; Chantraine F; Morel O; Bertholdt C; Braun T; Rijken MJ; Duvekot JJ;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1(Suppl 1):12-20. PubMed ID: 33483943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical Care in Placenta Accreta Spectrum Disorders-A Call to Action.
    Padilla CR; Shamshirsaz AA; Easter SR; Hess P; Smith C; El Sharawi N; Sandlin AT
    Am J Perinatol; 2023 Jul; 40(9):988-995. PubMed ID: 37336216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes of a False-Positive Antenatal Diagnosis of Placenta Accreta Spectrum.
    Salmanian B; Shamshirsaz AA; Fox KA; Asl NM; Erfani H; Detlefs SE; Coburn M; Espinoza J; Nassr A; Belfort MA; Clark SL; Shamshirsaz AA
    Am J Perinatol; 2024 Jan; 41(2):187-192. PubMed ID: 34666389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Literature Review of Placenta Accreta Spectrum Disorder: The Place of Expectant Management in Ethiopian Setup.
    Berhan Y; Urgie T
    Ethiop J Health Sci; 2020 Mar; 30(2):277-292. PubMed ID: 32165818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.